Search

everythinglearnresearchcommunity

for

Search:↓

Hormone replacement therapy can improve menopausal skin quality, but it's not recommended just for skin due to limited evidence.

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Hormone treatment caused hair loss, finasteride helped regrowth.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Localized estrogen treatments may improve skin quality with fewer risks than systemic hormone therapy.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

Reversed sequential therapy with cyproterone acetate was effective for treating women with hirsutism and related conditions.

A postmenopausal woman had high testosterone from her right adrenal gland, leading to recommended surgery.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Careful medical care is needed for those over 50 on hormone therapy during COVID-19.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Ovarian hyperthecosis should be considered in young women with severe male-like symptoms and can be managed with hormone treatments.

Sex hormone therapy is effective for certain skin conditions like acne and seborrhea, but less so for female hair loss and excessive hair growth.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Estrogen therapy helped regrow hair in a bald man.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

A woman's severe insulin resistance improved with treatment, but she still had high testosterone levels due to ovarian issues.

The man's fatigue and erectile dysfunction were improved by treating his obesity-related low testosterone without needing testosterone replacement.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

A 20-year-old woman with a rare form of Turner syndrome showed improvement with hormonal therapy and needs comprehensive care.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.